Alan Blake is a co-founder and CEO of Nuclein, LLC, an early-stage molecular diagnostics company that is developing a platform for rapid, inexpensive, and portable infectious disease detection.
Alan is also a co-founder and CEO of Yorktown Technologies. Yorktown is best known for GloFish®, brilliantly colored fluorescent fish, which are the world’s most visible example of consumer biotechnology and the only widely-marketed biotech animal. GloFish was sold to Spectrum Brands (NYSE: SPB) in 2017, by which point it had grown to drive an estimated 15% of all dollars spent in the U.S. aquarium fish market, or over $200 million in annual retail sales.
Additionally, Alan currently serves on the board of Falcon Structures, and he is an Advisory Partner for Trinity Private Equity Group. He has formerly served as the Austin chapter president of the Entrepreneur’s Organization, and as a board member of the Boys & Girls Club of the Austin Area, PrideBites, LLC, and Well Aware, as well as a mentor for Incubation Station (now SKU). Prior to co-founding Yorktown Technologies, Alan founded ClassMap, a venture-funded online learning company that ultimately served professors at 75 universities. Alan is also a winner of the prestigious Austin Under 40 award and holds 20 U.S. patents.
Alan graduated from the University of Texas at Austin, where he received a BBA with Highest Honors.